FG001 has completed all toxicity studies successfully
Copenhagen, Denmark, 28 May 2020 – FluoGuide is pleased to announce that FG001 has successfully completed all toxicity studies needed to initiate first clinical study in humans, and in a very short time compared to industry standard.FluoGuide has previously communicated its anticipation of a clean outcome of these studies which has now been confirmed. FluoGuide decided to conduct a full pre-clinical toxicity program for FG001, including species qualification studies, to document the safety of FG001 best possible before entering human clinical trials. The rationales were to give high